3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Other hematologic neoplasm
1
Conditions
Febrile Neutropenia
7
Neoplasms
5
Neutropenia
2
Hematologic Neoplasms
2
Fever
2
Sepsis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myeloid, Acute
1
Emergencies
1
Interventions
Vancomycin
2
Meropenem
2
Ceftazidime
2
pegfilgrastim
1
ofatumumab
1
Teicoplanin
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Piperacillin, Tazobactam Drug Combination
1
Metformin
1
Lenalidomide
1
Cloxacillin
1
Cilastatin, Imipenem Drug Combination
1
Cefepime
1
Bevacizumab
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Fever
×
Meropenem
×
Classical hematology
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled
NCT02463747
2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4
Unknown
110 enrolled